ASX - By Stock
|
CCV |
Re:
Ann: Change in substantial holding
|
|
Eey Ore
|
35 |
12K |
1 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
35
|
12K
|
1
|
|
ASX - By Stock
|
CCV |
Re:
Ann: Change in substantial holding
|
|
Eey Ore
|
35 |
12K |
5 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
35
|
12K
|
5
|
|
ASX - By Stock
|
CCV |
Re:
Ann: Change in substantial holding
|
|
Eey Ore
|
35 |
12K |
5 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
35
|
12K
|
5
|
|
ASX - By Stock
|
WDS |
Re:
Ann: Third Quarter 2022 Report
|
|
Eey Ore
|
41 |
20K |
1 |
20/10/22 |
20/10/22 |
ASX - By Stock
|
41
|
20K
|
1
|
|
ASX - By Stock
|
WDS |
Re:
Ann: Third Quarter 2022 Report
|
|
Eey Ore
|
41 |
20K |
5 |
20/10/22 |
20/10/22 |
ASX - By Stock
|
41
|
20K
|
5
|
|
ASX - By Stock
|
WDS |
Re:
Any body got dividends ?
|
|
Eey Ore
|
18 |
8.7K |
7 |
06/10/22 |
06/10/22 |
ASX - By Stock
|
18
|
8.7K
|
7
|
|
ASX - By Stock
|
ORG |
Re:
Ann: Origin to divest Beetaloo Basin interests
|
|
Eey Ore
|
8 |
3.8K |
4 |
20/09/22 |
20/09/22 |
ASX - By Stock
|
8
|
3.8K
|
4
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Brian Leedman appointed to the Board of OncoSil
|
|
Eey Ore
|
15 |
7.0K |
6 |
15/09/22 |
15/09/22 |
ASX - By Stock
|
15
|
7.0K
|
6
|
|
ASX - By Stock
|
CCV |
Re:
CCV Top 20 shareholders encouraging changes over the past year
|
|
Eey Ore
|
6 |
3.2K |
2 |
02/09/22 |
02/09/22 |
ASX - By Stock
|
6
|
3.2K
|
2
|
|
ASX - By Stock
|
CCV |
CCV Top 20 shareholders encouraging changes over the past year
|
|
Eey Ore
|
6 |
3.2K |
5 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
6
|
3.2K
|
5
|
|
ASX - By Stock
|
CCV |
Re:
Ann: Q4 FY 2022 Trading Update
|
|
Eey Ore
|
23 |
8.5K |
0 |
29/08/22 |
29/08/22 |
ASX - By Stock
|
23
|
8.5K
|
0
|
|
ASX - By Stock
|
AGL |
Re:
Ann: Dividend/Distribution - AGL
|
|
Eey Ore
|
14 |
9.1K |
1 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
14
|
9.1K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Bupa UK Approves Reimbursement for OncoSil in the UK
|
|
Eey Ore
|
42 |
18K |
8 |
04/07/22 |
04/07/22 |
ASX - By Stock
|
42
|
18K
|
8
|
|
ASX - By Stock
|
RFG |
Re:
Roar Roar Roar
|
|
Eey Ore
|
121 |
47K |
4 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
121
|
47K
|
4
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil PanCO Clinical Trial Presented At ESMO World WCGIC
|
|
Eey Ore
|
4 |
2.4K |
4 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
4
|
2.4K
|
4
|
|
ASX - By Stock
|
ORG |
Re:
Ann: Update on operating conditions and guidance
|
|
Eey Ore
|
31 |
14K |
2 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
31
|
14K
|
2
|
|
ASX - By Stock
|
CCV |
Re:
News: CCV Cash Converters International Posts Q3 Gross Loan Book Growth Up 21% On Pcp To A$203.7m
|
|
Eey Ore
|
9 |
6.1K |
4 |
04/05/22 |
04/05/22 |
ASX - By Stock
|
9
|
6.1K
|
4
|
|
ASX - By Stock
|
ORG |
Re:
Ann: Becoming a substantial holder
|
|
Eey Ore
|
2 |
665 |
5 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
2
|
665
|
5
|
|
ASX - By Stock
|
WDS |
Re:
Ann: First Quarter 2022 Report
|
|
Eey Ore
|
65 |
36K |
18 |
26/04/22 |
26/04/22 |
ASX - By Stock
|
65
|
36K
|
18
|
|
ASX - By Stock
|
OSL |
Re:
Ann: First Commerical Pancreas Treatment In Spain
|
|
Eey Ore
|
44 |
20K |
6 |
13/04/22 |
13/04/22 |
ASX - By Stock
|
44
|
20K
|
6
|
|
ASX - By Stock
|
OSL |
Re:
Ann: First Commerical Pancreas Treatment In Spain
|
|
Eey Ore
|
44 |
20K |
9 |
13/04/22 |
13/04/22 |
ASX - By Stock
|
44
|
20K
|
9
|
|
ASX - By Stock
|
CCV |
Re:
Ann: Change in substantial holding
|
|
Eey Ore
|
2 |
1.5K |
2 |
08/04/22 |
08/04/22 |
ASX - By Stock
|
2
|
1.5K
|
2
|
|
ASX - By Stock
|
CCV |
Re:
Ann: Change in substantial holding
|
|
Eey Ore
|
5 |
1.8K |
2 |
07/04/22 |
07/04/22 |
ASX - By Stock
|
5
|
1.8K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Fully-Funded Trial Approved In Germany
|
|
Eey Ore
|
21 |
13K |
1 |
03/04/22 |
03/04/22 |
ASX - By Stock
|
21
|
13K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Fully-Funded Trial Approved In Germany
|
|
Eey Ore
|
21 |
13K |
2 |
28/03/22 |
28/03/22 |
ASX - By Stock
|
21
|
13K
|
2
|
|
ASX - By Stock
|
ORG |
Re:
Ann: Origin to undertake $250 million share buy-back
|
|
Eey Ore
|
49 |
13K |
1 |
10/03/22 |
10/03/22 |
ASX - By Stock
|
49
|
13K
|
1
|
|
ASX - By Stock
|
WDS |
Re:
WPL@$40
|
|
Eey Ore
|
596 |
259K |
18 |
02/03/22 |
02/03/22 |
ASX - By Stock
|
596
|
259K
|
18
|
|
ASX - By Stock
|
CCV |
Re:
Ann: Half Year Financial Results Investor Presentation
|
|
Eey Ore
|
10 |
5.3K |
4 |
25/02/22 |
25/02/22 |
ASX - By Stock
|
10
|
5.3K
|
4
|
|
ASX - By Stock
|
ORG |
Re:
Ann: Appendix 3Y
|
|
Eey Ore
|
1 |
662 |
5 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
1
|
662
|
5
|
|
ASX - By Stock
|
ORG |
Re:
Ann: Origin Investor Presentation for Half Year Results
|
|
Eey Ore
|
12 |
4.0K |
1 |
17/02/22 |
17/02/22 |
ASX - By Stock
|
12
|
4.0K
|
1
|
|
ASX - By Stock
|
AGL |
Re:
Ann: AGL FY22 Half Year Report
|
|
Eey Ore
|
36 |
17K |
3 |
10/02/22 |
10/02/22 |
ASX - By Stock
|
36
|
17K
|
3
|
|
ASX - By Stock
|
AGL |
Re:
Ann: AGL FY22 Half Year Report
|
|
Eey Ore
|
36 |
17K |
2 |
10/02/22 |
10/02/22 |
ASX - By Stock
|
36
|
17K
|
2
|
|
Charts
|
ORG |
Re:
Origin Chart
|
|
Eey Ore
|
1.3K |
359K |
13 |
10/02/22 |
10/02/22 |
Charts
|
1.3K
|
359K
|
13
|
|
ASX - By Stock
|
ORG |
Re:
There appears to be some movement at the station
|
|
Eey Ore
|
46 |
18K |
2 |
10/02/22 |
10/02/22 |
ASX - By Stock
|
46
|
18K
|
2
|
|
ASX - By Stock
|
LKO |
Re:
7/2/22
|
|
Eey Ore
|
14 |
6.0K |
2 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
14
|
6.0K
|
2
|
|
Charts
|
ORG |
Re:
Origin Chart
|
|
Eey Ore
|
1.3K |
359K |
5 |
04/02/22 |
04/02/22 |
Charts
|
1.3K
|
359K
|
5
|
|
Charts
|
ORG |
Re:
Origin Chart
|
|
Eey Ore
|
1.3K |
359K |
3 |
04/02/22 |
04/02/22 |
Charts
|
1.3K
|
359K
|
3
|
|
Charts
|
ORG |
Re:
Origin Chart
|
|
Eey Ore
|
1.3K |
359K |
1 |
04/02/22 |
04/02/22 |
Charts
|
1.3K
|
359K
|
1
|
|
ASX - By Stock
|
ORG |
Re:
There appears to be some movement at the station
|
|
Eey Ore
|
46 |
18K |
1 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
46
|
18K
|
1
|
|
ASX - By Stock
|
ORG |
Re:
There appears to be some movement at the station
|
|
Eey Ore
|
46 |
18K |
1 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
46
|
18K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Eey Ore
|
11 |
5.3K |
2 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
11
|
5.3K
|
2
|
|
ASX - By Stock
|
ORG |
Re:
There appears to be some movement at the station
|
|
Eey Ore
|
46 |
18K |
5 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
46
|
18K
|
5
|
|
Charts
|
ORG |
Re:
Origin Chart
|
|
Eey Ore
|
1.3K |
359K |
2 |
28/01/22 |
28/01/22 |
Charts
|
1.3K
|
359K
|
2
|
|
ASX - By Stock
|
CCV |
Re:
Trading update
|
|
Eey Ore
|
12 |
5.7K |
1 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
12
|
5.7K
|
1
|
|
ASX - By Stock
|
ORG |
Re:
There appears to be some movement at the station
|
|
Eey Ore
|
46 |
18K |
3 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
46
|
18K
|
3
|
|
ASX - By Stock
|
WDS |
Re:
Ann: Fourth Quarter 2021 Report
|
|
Eey Ore
|
23 |
11K |
2 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
23
|
11K
|
2
|
|
ASX - By Stock
|
ORG |
Re:
$6 price target party
|
|
Eey Ore
|
69 |
33K |
5 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
69
|
33K
|
5
|
|
ASX - By Stock
|
ORG |
Re:
$6 price target party
|
|
Eey Ore
|
69 |
33K |
7 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
69
|
33K
|
7
|
|
ASX - By Stock
|
OSL |
Re:
Ann: PanCO Clinical Study on OncoSil Published in ESMO Open
|
|
Eey Ore
|
29 |
15K |
4 |
24/12/21 |
24/12/21 |
ASX - By Stock
|
29
|
15K
|
4
|
|
ASX - By Stock
|
ORG |
There appears to be some movement at the station
|
|
Eey Ore
|
46 |
18K |
3 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
46
|
18K
|
3
|
|